Loading clinical trials...
Loading clinical trials...
A Randomized, Open-Label, Parallel Group, Fixed Energy Deficit Methodology Trial to Characterize Early Efficacy Biomarkers During Treatment of Obesity in Adult, Obese, Male Subjects.
Conditions
Interventions
caloric restriction - 10%
caloric restriction - 25%
+2 more
Locations
2
Australia
Pfizer Investigational Site
Adelaide, South Australia, Australia
Pfizer Investigational Site
North Adelaide, South Australia, Australia
Start Date
October 1, 2006
Completion Date
March 1, 2008
Last Updated
March 23, 2009
NCT07472881
NCT01143454
NCT07010757
NCT06223555
NCT06989203
NCT07237750
Lead Sponsor
Pfizer
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions